These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7694994)

  • 1. Effects of erucic acid therapy on Japanese patients with X-linked adrenoleukodystrophy.
    Asano J; Suzuki Y; Yajima S; Inoue K; Shimozawa N; Kondo N; Murase M; Orii T
    Brain Dev; 1994; 16(6):454-8. PubMed ID: 7694994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary erucic acid therapy for X-linked adrenoleukodystrophy.
    Rizzo WB; Leshner RT; Odone A; Dammann AL; Craft DA; Jensen ME; Jennings SS; Davis S; Jaitly R; Sgro JA
    Neurology; 1989 Nov; 39(11):1415-22. PubMed ID: 2682348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil".
    van Geel BM; Assies J; Haverkort EB; Koelman JH; Verbeeten B; Wanders RJ; Barth PG
    J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):290-9. PubMed ID: 10449548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience on therapy of adrenoleukodystrophy and adrenomyeloneuropathy.
    Uziel G; Bertini E; Bardelli P; Rimoldi M; Gambetti M
    Dev Neurosci; 1991; 13(4-5):274-9. PubMed ID: 1817033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is subclinical adrenal failure in adrenoleukodystrophy/adrenomyeloneuropathy reversible?
    Cappa M; Bizzarri C; Giannone G; Aiello C; Di Biase A
    J Endocrinol Invest; 2011 Nov; 34(10):753-6. PubMed ID: 21399389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy.
    Aubourg P; Adamsbaum C; Lavallard-Rousseau MC; Rocchiccioli F; Cartier N; Jambaqué I; Jakobezak C; Lemaitre A; Boureau F; Wolf C
    N Engl J Med; 1993 Sep; 329(11):745-52. PubMed ID: 8350883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and therapeutic aspects of adrenoleukodystrophy and adrenomyeloneuropathy.
    Moser HW
    J Neuropathol Exp Neurol; 1995 Sep; 54(5):740-5. PubMed ID: 7666063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical course of childhood and adolescent adrenoleukodystrophy before and after Lorenzo's oil.
    Suzuki Y; Imamura A; Shimozawa N; Kondo N
    Brain Dev; 2001 Mar; 23(1):30-3. PubMed ID: 11226726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil.
    Moser HW; Raymond GV; Lu SE; Muenz LR; Moser AB; Xu J; Jones RO; Loes DJ; Melhem ER; Dubey P; Bezman L; Brereton NH; Odone A
    Arch Neurol; 2005 Jul; 62(7):1073-80. PubMed ID: 16009761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of X-linked adrenoleukodystrophy.
    Semmler A; Köhler W; Jung HH; Weller M; Linnebank M
    Expert Rev Neurother; 2008 Sep; 8(9):1367-79. PubMed ID: 18759549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glyceroltrioleate/glyceroltrierucate therapy in 16 patients with X-chromosomal adrenoleukodystrophy/adrenomyeloneuropathy: effect on clinical, biochemical and neurophysiological parameters.
    Korenke GC; Hunneman DH; Kohler J; Stöckler S; Landmark K; Hanefeld F
    Eur J Pediatr; 1995 Jan; 154(1):64-70. PubMed ID: 7895759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lovastatin therapy for X-linked adrenoleukodystrophy: clinical and biochemical observations on 12 patients.
    Pai GS; Khan M; Barbosa E; Key LL; Craver JR; Curé JK; Betros R; Singh I
    Mol Genet Metab; 2000 Apr; 69(4):312-22. PubMed ID: 10870849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model-based approach to assess the exposure-response relationship of Lorenzo's oil in adrenoleukodystrophy.
    Ahmed MA; Kartha RV; Brundage RC; Cloyd J; Basu C; Carlin BP; Jones RO; Moser AB; Fatemi A; Raymond GV
    Br J Clin Pharmacol; 2016 Jun; 81(6):1058-66. PubMed ID: 26836218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenoleukodystrophy: magnetic resonance follow-up after Lorenzo's oil therapy.
    Duchesne N; Dufour M; Bouchard G; Grondin P; Lemieux B
    Can Assoc Radiol J; 1995 Oct; 46(5):386-91. PubMed ID: 7552831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil.
    Poulos A; Gibson R; Sharp P; Beckman K; Grattan-Smith P
    Ann Neurol; 1994 Nov; 36(5):741-6. PubMed ID: 7979219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy.
    Loes DJ; Fatemi A; Melhem ER; Gupte N; Bezman L; Moser HW; Raymond GV
    Neurology; 2003 Aug; 61(3):369-74. PubMed ID: 12913200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenoleukodystrophy in a Chinese boy.
    Wong V
    Brain Dev; 1992 Jul; 14(4):276-7. PubMed ID: 1279999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [X-linked adrenoleukodystrophy].
    Aubourg P
    Ann Endocrinol (Paris); 2007 Dec; 68(6):403-11. PubMed ID: 17532287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute onset of X-linked adrenoleukodystrophy mimicking encephalitis.
    Zammarchi E; Donati MA; Tucci F; Fonda C; Fanelli F; Pazzaglia R
    Brain Dev; 1994; 16(3):238-40. PubMed ID: 7943611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of an adrenomyeloneuropathy patient with Lorenzo's oil and supplementation with docosahexaenoic acid--a case report.
    Terre'Blanche G; van der Walt MM; Bergh JJ; Mienie LJ
    Lipids Health Dis; 2011 Aug; 10():152. PubMed ID: 21871076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.